What is the appropriate clindamycin dosage for a 12‑kg child with suspected aspiration pneumonia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Dosis de Clindamicina para Neumonía Aspirativa en Niña de 12 kg

Para una niña de 12 kg con sospecha de neumonía aspirativa, la dosis de clindamicina es 40 mg/kg/día dividida cada 6-8 horas por vía intravenosa, lo que equivale a 480 mg/día (120-160 mg cada 6-8 horas). 1

Justificación de la Dosis

Las guías de la Pediatric Infectious Diseases Society y la Infectious Diseases Society of America (2011) establecen claramente que para patógenos anaerobios y Staphylococcus aureus (comunes en neumonía aspirativa), la dosis parenteral de clindamicina es 40 mg/kg/día dividida cada 6-8 horas 1. Esta dosis se aplica específicamente cuando se sospecha:

  • Bacterias anaerobias (frecuentes en aspiración)
  • S. aureus sensible a meticilina
  • S. aureus resistente a meticilina (MRSA) susceptible a clindamicina

Cálculo Específico para Esta Paciente

Para 12 kg:

  • Dosis diaria total: 40 mg/kg/día × 12 kg = 480 mg/día
  • Dividida cada 6 horas: 120 mg cada 6 horas
  • Dividida cada 8 horas: 160 mg cada 8 horas

La etiqueta de la FDA confirma que para pacientes pediátricos de 1 mes a 16 años, la dosis es 20-40 mg/kg/día en 3-4 dosis divididas, usando las dosis más altas para infecciones severas 2.

Consideraciones Importantes sobre Neumonía Aspirativa

La clindamicina es particularmente apropiada para neumonía aspirativa porque:

  1. Cobertura anaeróbica: La neumonía aspirativa típicamente involucra flora orofaríngea con anaerobios (Peptostreptococcus, Fusobacterium, Prevotella) 1

  2. Evidencia de eficacia: Un estudio randomizado controlado demostró que clindamicina (30 mg/kg/día) fue igualmente efectiva que penicilina para neumonía aspirativa en niños, con tiempo mediano de alta de 3.4 días 3

  3. Cobertura de S. aureus: Si hay sospecha clínica de S. aureus (común en aspiración severa), clindamicina proporciona cobertura adecuada 1

Vía de Administración

  • Intravenosa: Diluir para que la concentración no exceda 18 mg/mL
  • Velocidad de infusión: No exceder 30 mg/minuto
  • Tiempo de infusión recomendado:
    • Para 120-160 mg: infundir en 10-20 minutos 2

Advertencias Críticas

⚠️ Monitorear diarrea: Si aparece diarrea durante el tratamiento, considerar Clostridioides difficile y suspender clindamicina inmediatamente 2

⚠️ Resistencia local: Verificar patrones de susceptibilidad locales, ya que la resistencia a clindamicina está aumentando en ciertas áreas geográficas para S. pneumoniae y S. aureus 1

⚠️ Prueba D-zone: Si se aísla MRSA, realizar prueba de inducción de resistencia a clindamicina (D-zone test), ya que algunos aislamientos resistentes a macrólidos pueden desarrollar resistencia inducible a clindamicina 2

Transición a Terapia Oral

Una vez que la paciente mejore clínicamente y pueda tolerar vía oral:

  • Dosis oral: 30-40 mg/kg/día dividida en 3-4 dosis 1
  • Para 12 kg: 360-480 mg/día (90-120 mg cada 6-8 horas)

Duración del Tratamiento

La duración debe ser la más corta efectiva, típicamente 7-10 días dependiendo de la respuesta clínica. Para infecciones por estreptococo beta-hemolítico, continuar al menos 10 días 1.

References

Related Questions

For a 60‑kg child with community‑acquired pneumonia, what is the appropriate antibiotic regimen?
In a 2‑year‑old child with a three‑day history of dry cough, yellow rhinorrhea, and oropharyngeal plaques who is taking amoxicillin and has developed diarrhea, what is the appropriate management?
What is the recommended outpatient antibiotic regimen for a 5‑year‑old child (≈20 kg) with community‑acquired pneumonia?
What is the recommended amoxicillin dosage for treating community-acquired pneumonia in adults and children?
What is the appropriate drug treatment for pneumonitis in a 3‑year‑old child weighing 10 kg?
What is the prognosis and recommended follow‑up for a 57‑year‑old man with stage IV follicular lymphoma who is in a second remission lasting nearly five years after R‑CHOP and R² (rituximab + lenalidomide) therapy?
In a patient with a ventriculoperitoneal (VP) shunt who develops an acute perforated, inflamed abdomen resulting in hydrocephalus and pneumocephalus, does the one‑way shunt valve prevent abdominal gases from migrating into the central nervous system?
Should a patient with hereditary angioedema who has undergone a total laryngectomy continue regular prophylactic Cinryze (plasma‑derived C1‑esterase inhibitor) or use it only as needed when his throat feels like it is swelling?
What are the indications, dosing regimen, and monitoring parameters for ivabradine in hypertrophic obstructive cardiomyopathy?
What is the appropriate diagnosis and treatment plan for a 32-year-old male with recurrent major depressive disorder, generalized anxiety disorder, multiple prior suicide attempts, a recent acute suicidal crisis precipitated by a panic reaction to quetiapine (Seroquel) and trazodone, ongoing daily cannabis (THC) and kratom use, tobacco dependence, flat affect, poor insight, and minimal cooperation?
What is the appropriate immediate‑release Cymbalta (duloxetine) dose for a patient currently on 30 mg extended‑release?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.